Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Krummel

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Experimental Medicine|August 1, 1995
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulationM F Krummel, J P Allison
The Journal of Experimental Medicine|June 1, 1996
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cellsM F Krummel, J P Allison
Science (New York, N.Y.)|November 10, 1995
The Yin and Yang of T cell costimulationJ P Allison, M F Krummel
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Differential coupling of second signals for cytotoxicity and proliferation in CD8+ T cell effectors: amplification of the lytic potential by B7M F Krummel, W R Heath, J Allison
International Immunology|April 1, 1996
Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivoM F Krummel, T J Sullivan, J P Allison
Science (New York, N.Y.)|March 22, 1996
Enhancement of antitumor immunity by CTLA-4 blockadeD R Leach, M F Krummel, J P Allison
European Journal of Immunology|February 17, 1998
The nature of the signals regulating CD8 T cell proliferative responses to CD8alpha+ or CD8alpha- dendritic cellsK D Winkel, V Kronin, M F Krummel, et al.
Science (New York, N.Y.)|August 26, 2000
Differential clustering of CD4 and CD3zeta during T cell recognitionM F Krummel, M D Sjaastad, C Wülfing, et al.
Journal of Neuroimmunology|March 1, 1997
Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitisA A Hurwitz, T J Sullivan, M F Krummel, et al.
Nature|April 7, 1999
Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cellsC Kurts, F R Carbone, M F Krummel, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Experimental Medicine|August 1, 1995
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulationM F Krummel, J P Allison
The Journal of Experimental Medicine|June 1, 1996
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cellsM F Krummel, J P Allison
Science (New York, N.Y.)|November 10, 1995
The Yin and Yang of T cell costimulationJ P Allison, M F Krummel
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Differential coupling of second signals for cytotoxicity and proliferation in CD8+ T cell effectors: amplification of the lytic potential by B7M F Krummel, W R Heath, J Allison
International Immunology|April 1, 1996
Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivoM F Krummel, T J Sullivan, J P Allison
Science (New York, N.Y.)|March 22, 1996
Enhancement of antitumor immunity by CTLA-4 blockadeD R Leach, M F Krummel, J P Allison
European Journal of Immunology|February 17, 1998
The nature of the signals regulating CD8 T cell proliferative responses to CD8alpha+ or CD8alpha- dendritic cellsK D Winkel, V Kronin, M F Krummel, et al.
Science (New York, N.Y.)|August 26, 2000
Differential clustering of CD4 and CD3zeta during T cell recognitionM F Krummel, M D Sjaastad, C Wülfing, et al.
Journal of Neuroimmunology|March 1, 1997
Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitisA A Hurwitz, T J Sullivan, M F Krummel, et al.
Nature|April 7, 1999
Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cellsC Kurts, F R Carbone, M F Krummel, et al.
Pageof 2